726 related articles for article (PubMed ID: 28494972)
1. Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony.
Forner S; Baglietto-Vargas D; Martini AC; Trujillo-Estrada L; LaFerla FM
Trends Neurosci; 2017 Jun; 40(6):347-357. PubMed ID: 28494972
[TBL] [Abstract][Full Text] [Related]
2. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
3. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
Rajmohan R; Reddy PH
J Alzheimers Dis; 2017; 57(4):975-999. PubMed ID: 27567878
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Tau in Alzheimer's Disease.
Ittner A; Ittner LM
Neuron; 2018 Jul; 99(1):13-27. PubMed ID: 30001506
[TBL] [Abstract][Full Text] [Related]
6. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
[TBL] [Abstract][Full Text] [Related]
7. The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.
Crimins JL; Pooler A; Polydoro M; Luebke JI; Spires-Jones TL
Ageing Res Rev; 2013 Jun; 12(3):757-63. PubMed ID: 23528367
[TBL] [Abstract][Full Text] [Related]
8. Tau acts as a mediator for Alzheimer's disease-related synaptic deficits.
Liao D; Miller EC; Teravskis PJ
Eur J Neurosci; 2014 Apr; 39(7):1202-13. PubMed ID: 24712999
[TBL] [Abstract][Full Text] [Related]
9. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
10. Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease.
Pickett EK; Herrmann AG; McQueen J; Abt K; Dando O; Tulloch J; Jain P; Dunnett S; Sohrabi S; Fjeldstad MP; Calkin W; Murison L; Jackson RJ; Tzioras M; Stevenson A; d'Orange M; Hooley M; Davies C; Colom-Cadena M; Anton-Fernandez A; King D; Oren I; Rose J; McKenzie CA; Allison E; Smith C; Hardt O; Henstridge CM; Hardingham GE; Spires-Jones TL
Cell Rep; 2019 Dec; 29(11):3592-3604.e5. PubMed ID: 31825838
[TBL] [Abstract][Full Text] [Related]
11. Tau is not necessary for amyloid-β-induced synaptic and memory impairments.
Puzzo D; Argyrousi EK; Staniszewski A; Zhang H; Calcagno E; Zuccarello E; Acquarone E; Fa' M; Li Puma DD; Grassi C; D'Adamio L; Kanaan NM; Fraser PE; Arancio O
J Clin Invest; 2020 Sep; 130(9):4831-4844. PubMed ID: 32544084
[TBL] [Abstract][Full Text] [Related]
12. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
14. A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.
Han P; Shi J
J Alzheimers Dis; 2016 Apr; 52(4):1461-70. PubMed ID: 27104897
[TBL] [Abstract][Full Text] [Related]
15. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
[TBL] [Abstract][Full Text] [Related]
16. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
17. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
[TBL] [Abstract][Full Text] [Related]
18. The intersection of amyloid beta and tau at synapses in Alzheimer's disease.
Spires-Jones TL; Hyman BT
Neuron; 2014 May; 82(4):756-71. PubMed ID: 24853936
[TBL] [Abstract][Full Text] [Related]
19. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
Gouras GK; Willén K; Faideau M
Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
[TBL] [Abstract][Full Text] [Related]
20. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.
Gouras GK; Tampellini D; Takahashi RH; Capetillo-Zarate E
Acta Neuropathol; 2010 May; 119(5):523-41. PubMed ID: 20354705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
